Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amar Gajjar, MD
St. Jude Children's Research Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sydney Children'S Hospital
Randwick, New South Wales, Australia
- Children'S Hospital at Westmead
Westmead, New South Wales, Australia
- Lady Cilento Children'S Hospital, Brisbane
Brisbane, Queensland, Australia
- Royal Children'S Hospital
Parkville, Victoria, Australia
- Hospital for Sick Children
Toronto, Ontario, Canada
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Texas Children'S Cancer Center and Hematology Service at Texas Children'S Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2003
- Primary completion
- 31 Dec 2016
- Completion
- 31 Dec 2023
- Last update posted
- 8 Feb 2024
- Registered enrollment
- 416
- Registry id
- NCT00085202
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.